Ascelia Pharma AB (publ)

DB:7ZA Stock Report

Market Cap: €35.1m

Ascelia Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:7ZA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 25Buy€7,399Peter BensonIndividual23,000€0.32

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 7ZA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,620,2431.96%
Individual Insiders7,197,0965.39%
Institutions41,325,12230.9%
General Public82,392,99961.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.1%.


Top Shareholders

Top 23 shareholders own 38.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Nordnet Pensionsförsäkring AB
14,296,421€3.8m0%0.47%
5.53%
Avanza Fonder AB
7,383,957€1.9m0%0.02%
3.58%
Sunstone Life Science Ventures A/S
4,778,129€1.3m0%69.46%
3.48%
Fourth Swedish National Pension Fund (AP4)
4,644,266€1.2m0%no data
3.09%
Ostvast Capital Management Limited
4,132,896€1.1m0%10.37%
2.36%
Mats Thoren
3,152,568€828.6k0%no data
2.15%
Handelsbanken Asset Management
2,872,136€754.9k0%no data
1.13%
Oscar Ahlgren
1,503,700€395.2k0%no data
1.11%
Swedbank Försäkring AB
1,477,807€388.4k0%1.03%
1.05%
Connys Alltransporter AB
1,400,000€368.0k0%no data
0.85%
Søren Andresen
1,135,000€298.3k0%no data
0.8%
Spogárd Holding Aps
1,070,243€281.3k0%no data
0.8%
Salenia AB
1,065,821€280.1k0%0.3%
0.6%
Magnus Corfitzen
806,720€212.0k0%no data
0.34%
Nordnet Livsforsikring AS
460,134€120.9k0%0.4%
0.16%
SEB Funds AB
213,555€56.1k0%no data
0.13%
Peter Benson
177,775€46.7k-28.9%no data
0.11%
Jollingham Ab
150,000€39.4k0%no data
0.1%
Andreas Norlin
138,164€36.3k1.29%no data
0.082%
Helena Wennerström
108,944€28.6k22.1%no data
0.058%
Jennie Wilborgsson
77,672€20.4k-17.5%no data
0.057%
Marie Källström
76,553€20.1k0%no data
0.015%
Hans Maier
20,000€5.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/01 08:59
End of Day Share Price 2026/07/01 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ascelia Pharma AB (publ) is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier Sponsored
Lars HevrengDanske Bank
Maria Karlsson OsipovaDNB Carnegie Commissioned Research